EMA flags rare vision risk in users of weight-loss drugsEuropean regulators have issued a warning that Novo Nordisk’s popular weight-loss and diabetes medications — Wegovy, Ozempic, and Rybelsus — may be associated…7 June 2025 · 2 MIN READ
